Investigation Overview
April 15, 2016 (Shareholders Foundation) - An investigation on behalf of investors of aTyr Pharma Inc (NASDAQ:LIFE) shares over potential securities laws violations by aTyr Pharma and certain of its directors and officers in connection certain financial statements was announced.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of aTyr Pharma Inc (NASDAQ:LIFE) concerning whether a series of statements by aTyr Pharma regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
aTyr Pharma Inc went public in May 2015 and shares of aTyr Pharma Inc (NASDAQ:LIFE) rose to as high as $27.88 per share in June 2015. Since then shares of aTyr Pharma Inc (NASDAQ:LIFE) have declined significantly. In fact, shares of aTyr Pharma Inc declined to as low as $3.03 per share on April 8, 2016.